Researchers at UC San Diego recently created a pharmacophore model and conducted data mining of the conformational database of FDA-approved drugs that identifies 64 compounds as potential inhibitors of the COVID-19 protease. Among the selected compounds are two HIV protease inhibitors, two hepatitis C protease inhibitors, and three drugs that have already shown positive results in testing with COVID-19.
![](https://sciencenewsnet.in/wp-content/uploads/2020/04/PR20200415_COVID-19_Protease_Inhibitors_640x400.jpg)